Do Institutions Own SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Shares?

In This Article:

Every investor in SMS Pharmaceuticals Limited (NSE:SMSPHARMA) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. I quite like to see at least a little bit of insider ownership. As Charlie Munger said ‘Show me the incentive and I will show you the outcome.’

With a market capitalization of ₹5.4b, SMS Pharmaceuticals is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions are not really that prevalent on the share registry. Let’s take a closer look to see what the different types of shareholder can tell us about SMSPHARMA.

See our latest analysis for SMS Pharmaceuticals

NSEI:SMSPHARMA Ownership Summary December 20th 18
NSEI:SMSPHARMA Ownership Summary December 20th 18

What Does The Lack Of Institutional Ownership Tell Us About SMS Pharmaceuticals?

We don’t tend to see institutional investors holding stock of companies that are very risky, thinly traded, or very small. Though we do sometimes see large companies without institutions on the register, it’s not particularly common.

There could be various reasons why no institutions own shares in a company. Typically, small, newly listed companies don’t attract much attention from fund managers, because it would not be possible for large fund managers to build a meaningful position in the company. On the other hand, it’s always possible that professional investors are avoiding a company because they don’t think it’s the best place for their money. SMS Pharmaceuticals’s earnings and revenue track record (below) may not be compelling to institutional investors — or they simply might not have looked at the business closely.

NSEI:SMSPHARMA Income Statement Export December 20th 18
NSEI:SMSPHARMA Income Statement Export December 20th 18

Hedge funds don’t have many shares in SMS Pharmaceuticals. Our information suggests that there isn’t any analyst coverage of the stock, so it is probably little known.

Insider Ownership Of SMS Pharmaceuticals

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our most recent data indicates that insiders own the majority of SMS Pharmaceuticals Limited. This means they can collectively make decisions for the company. That means they own ₹3.7b worth of shares in the ₹5.4b company. That’s quite meaningful. Most would be pleased to see the board is investing alongside them. You may wish todiscover (for free) if they have been buying or selling.